Anuloma Viloma TimerSix weeks of breathwork moved anxiety harder than almost any pill on the market.
That is not a slogan. It is the headline finding of a 2025 randomised controlled trial published in the Journal of Affective Disorders. One hundred and seven adults sat through six weekly online sessions of conscious connected breathwork. Their anxiety scores dropped from 43.87 to 33.31. The effect size, Cohen’s d, came in at 1.44. Most pharmaceutical anxiety trials produce effect sizes between 0.3 and 0.5. The control group in this same study, the people on a waitlist, ended up at 0.24.
Cohen’s d is the standard way researchers translate a treatment’s punch into a single comparable number. A 0.2 is a small effect. A 0.5 is moderate. A 0.8 is large. A 1.44 is, by clinical convention, very large, and it puts breathwork in a part of the bar chart that almost nothing in this category reaches.
What the trial actually measured
The intervention was conscious connected breathwork, delivered online, six weekly sessions of ninety minutes each. The control group did nothing different. Anxiety was measured with a validated questionnaire before and after. The intervention group’s average score dropped roughly ten points, which is the kind of change that translates into a real shift in daily life, not a statistical curiosity.
Conscious connected breathwork is not Anuloma Viloma. It is a different technique with its own structure. But it sits in the same family: paced, conscious, nasal-led breathing, done on a clock. The reason this study matters for an alternate-nostril-breathing audience is that it confirms something the wider research base has been hinting at for years. Structured breathing protocols, delivered consistently, change anxiety in a way that holds up under randomisation, blinding, and effect-size scrutiny.
Anuloma Viloma has its own science layer underneath it. A 2017 randomised controlled trial showed Nadi Shodhana was three times as effective at reducing anxiety as mindful breath awareness alone. A 2018 study on thirty-minute daily practice found a meaningful drop in perceived stress scores over three months. A 2026 paper indexed on PubMed Central measured Nadi Shuddhi pranayama against heart rate variability in young adults and recorded a measurable shift inside a single session. The 2025 Cohen’s d 1.44 result does not stand alone. It sits at the top of a stack.
Why the number is the story
Most antidepressants entering clinical trials produce effect sizes that hover between 0.3 and 0.5 against placebo. Many of them are still considered useful drugs. They get prescribed. They help people. Nobody is suggesting throwing them away. But it is worth saying out loud: a six-week breathing protocol just outproduced almost the entire pharmacological category on the headline metric the field uses to compare treatments.
This is the kind of finding that ought to change the default conversation. When anxiety hits, the reflex move is still pharmaceutical, then maybe therapy, then maybe meditation, then somewhere down the list, breathwork. The data is now suggesting the order is upside down for a meaningful subset of people. Not for everyone. Not as a replacement for medication anyone is currently relying on. But as a starting point, as a five-minute daily floor, the case is no longer “it might help”. The case is “it produced one of the largest individual-study effect sizes anyone has measured for anxiety.”
What April 28 has to do with it
April 28 is the International Labour Organization’s World Day for Safety and Health at Work. It is built around occupational safety, but the modern version of that conversation has expanded to cover psychosocial risk: workplace anxiety, burnout, autonomic dysregulation. The ILO’s own materials this year touch on the cost of chronic workplace stress in lost productivity, sick days, and long-term cardiovascular risk.
A five-minute Anuloma Viloma session before a high-stakes meeting is not a corporate wellness perk. It is a practice with measurable effects on heart rate variability, with a separate randomised controlled trial three times as effective as mindfulness alone, and with the new 2025 RCT showing six-week effect sizes that pharmaceutical trials would envy. It costs nothing. It runs on a free timer on your phone. It runs on your Apple Watch.
The framing matters. Workplaces have been quietly tracking burnout for years through the proxies they have access to: heart rate, sleep, productivity dips. The autonomic mechanism behind those numbers is the same one structured nasal breathing trains. Five minutes between meetings, alternate nostrils, on a clock, is the cheapest available intervention for the thing that costs companies the most.
What “five minutes a day” actually requires
Anuloma Viloma is the simplest of the structured pranayama practices. Close one nostril with your right thumb. Inhale through the open one. Close it. Open the first. Exhale. Inhale. Close. Open. Exhale. Repeat for five minutes. The Anuloma Viloma Timer counts the rounds, holds the pacing steady, and shows you live heart rate on your Apple Watch if you wear one. Free on the App Store. No subscription necessary. No streak gamification. No algorithm prompting you to come back and consume more content.
What there is, is a five-minute window once a day where your nervous system gets a structured chance to recalibrate. The 2025 Cohen’s d data is not promising you a transformed life. It is suggesting the floor of effect, even at a six-week scale, is bigger than most things you could plausibly compare it to.
Five minutes. Two nostrils. One number that quietly tells the truth.
Sources: ScienceDirect, Journal of Affective Disorders, “Efficacy of online conscious connected breathwork in reducing symptoms of anxiety: A randomized waitlist control trial” (2025/2026). PubMed Central PMC12331837, “Exploring the Immediate Effects of Nadi Shuddhi Pranayama on Heart Rate Variability Among Young Adults” (2026). LifeX Research Corporation, “Vagus Nerve Exercises: The 1 Wellness Trend of 2026.”